Wilson Sonsini Goodrich & Rosati advised Sudo on intellectual property matters related to the transaction. Sudo Biosciences (“Sudo”) announced the close of a $116 million Series B...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here